Learn how pharmaceutical manufacturers can build owned, validated AI infrastructure for critical GMP processes, change control, and regulatory compliance.
Learn why manufacturing AI pilots fail to deliver measurable ROI and how to tie projects to financial baselines, executive ownership, targets, and exit criteria.